# Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

> **NCT00395655** · PHASE2 · TERMINATED · sponsor: **National Institute of Cancerología** · enrollment: 43 (—)

## Conditions studied

- Locally Advanced Breast Cancer

## Interventions

- **DRUG:** Hydralazine and magnesium valproate administration
- **PROCEDURE:** Core-needle biopsy of the breast

## Key facts

- **NCT ID:** NCT00395655
- **Lead sponsor:** National Institute of Cancerología
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 43 (—)
- **Last updated:** 2006-11-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395655, "Hydralazine and Valproate Added to Chemotherapy for Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00395655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*